Elite in Neonatal Sepsis

Emmanuel J. Roilides

Thessaloniki, ESYE12, GR 
Elite in Neonatal Sepsis
Thessaloniki, ESYE12, GR 
OverviewLocationsClinical Research

Overview

Emmanuel Roilides practices in Thessaloniki, Greece. Mr. Roilides is rated as an Elite expert by MediFind in the treatment of Neonatal Sepsis. His top areas of expertise are Sepsis, Neonatal Sepsis, Mucormycosis, Bone Marrow Transplant, and Kidney Transplant.

His clinical research consists of co-authoring 322 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Neonatal Sepsis.

Gender
Male

Locations

Thessaloniki, ESYE12 54642, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
An Open-label, Non-comparator, Multicenter Study to Describe the Pharmacokinetics (PK), Pharmacodynamics (PD; Viral Load) and Safety Following a Single Intravenous or Intramuscular Dose of Sotrovimab in Pediatric Participants With Mild to Moderate COVID-19 at High Risk of Disease Progression
Enrollment Status: Terminated
Publish Date: January 03, 2024
Intervention Type: Biological
Study Drug: Sotrovimab
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
View 1 Less Clinical Trial

322 Total Publications

Chimeric Antigen Receptor Immunotherapy for Infectious Diseases: Current Advances and Future Perspectives.
Chimeric Antigen Receptor Immunotherapy for Infectious Diseases: Current Advances and Future Perspectives.
Journal: Pathogens (Basel, Switzerland)
Published: July 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roilides's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile